THOMAS, Astrid Maria
 Distribuzione geografica
Continente #
NA - Nord America 11.138
EU - Europa 9.472
AS - Asia 7.686
SA - Sud America 1.012
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 21
Totale 29.459
Nazione #
US - Stati Uniti d'America 10.939
SG - Singapore 2.960
CN - Cina 2.313
IT - Italia 1.759
RU - Federazione Russa 1.579
UA - Ucraina 1.372
IE - Irlanda 1.139
GB - Regno Unito 976
TR - Turchia 883
BR - Brasile 813
SE - Svezia 707
FR - Francia 686
VN - Vietnam 674
DE - Germania 562
IN - India 370
FI - Finlandia 321
CA - Canada 111
HK - Hong Kong 98
AR - Argentina 75
NL - Olanda 69
BD - Bangladesh 65
MX - Messico 63
JP - Giappone 61
PL - Polonia 58
ES - Italia 44
IQ - Iraq 39
AT - Austria 34
ZA - Sudafrica 34
CZ - Repubblica Ceca 32
EC - Ecuador 29
ID - Indonesia 25
CO - Colombia 24
LU - Lussemburgo 24
PK - Pakistan 24
BE - Belgio 23
IR - Iran 23
KR - Corea 23
EU - Europa 20
CH - Svizzera 19
MA - Marocco 19
VE - Venezuela 18
CL - Cile 16
UZ - Uzbekistan 16
EG - Egitto 14
PE - Perù 14
AU - Australia 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
RO - Romania 12
MY - Malesia 11
SA - Arabia Saudita 11
JO - Giordania 9
KE - Kenya 9
PH - Filippine 9
DK - Danimarca 8
GR - Grecia 8
PT - Portogallo 8
NZ - Nuova Zelanda 7
SN - Senegal 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
HN - Honduras 6
LB - Libano 6
PY - Paraguay 6
AO - Angola 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
DZ - Algeria 4
ET - Etiopia 4
GY - Guiana 4
KZ - Kazakistan 4
SI - Slovenia 4
TW - Taiwan 4
AL - Albania 3
KG - Kirghizistan 3
NP - Nepal 3
PS - Palestinian Territory 3
SM - San Marino 3
AM - Armenia 2
CY - Cipro 2
GT - Guatemala 2
HU - Ungheria 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
DM - Dominica 1
GA - Gabon 1
Totale 29.441
Città #
Singapore 2.148
Jacksonville 1.494
Chandler 1.333
San Jose 1.183
Dublin 1.121
Ashburn 698
Southend 690
Princeton 567
Dallas 491
Beijing 485
Izmir 454
Nanjing 443
Wilmington 298
Los Angeles 277
Dearborn 260
Cambridge 241
Ho Chi Minh City 221
Santa Clara 213
Tongling 183
Altamura 162
The Dalles 156
Nanchang 148
Buffalo 144
Hanoi 140
New York 138
Chieti 125
Munich 116
Ann Arbor 114
Council Bluffs 114
Woodbridge 109
Moscow 101
Rome 97
Boardman 93
São Paulo 91
Hong Kong 84
Shenyang 84
Milan 83
Hebei 76
Redondo Beach 71
Tianjin 70
Orem 66
Houston 63
Jiaxing 61
Grevenbroich 53
Hefei 51
Helsinki 51
Kunming 49
Pescara 46
Washington 46
Toronto 45
London 44
Tokyo 43
Norwalk 41
Brooklyn 40
Chennai 39
Warsaw 39
Hangzhou 38
Changsha 37
Jinan 34
Atlanta 32
Montreal 31
Da Nang 30
Denver 30
Frankfurt am Main 29
Stockholm 29
Turku 29
Lanzhou 28
Chicago 27
Haiphong 27
Manchester 26
Florence 25
Belo Horizonte 24
Rio de Janeiro 24
Poplar 23
Naples 22
Biên Hòa 21
Dong Ket 21
Johannesburg 21
Augusta 20
Mexico City 20
Seoul 20
Changchun 19
Orange 19
Phoenix 19
Ardabil 18
Falls Church 18
Ningbo 18
San Francisco 18
Taizhou 18
Amsterdam 17
Nuremberg 17
Baghdad 16
Boston 16
Brno 16
Charlotte 16
Dudelange 16
Mumbai 16
Paris 16
Brussels 15
Hải Dương 15
Totale 16.884
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.088
Emergenza neurologica - tempesta distonica: diagnosi e terapia 483
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 313
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 278
Pre-trattamento antiematico per Test/terapia all'apomorfina 197
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 183
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 178
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 177
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 176
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 164
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 163
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 163
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 162
Akinetic crisis in Dementia with Lewy Bodies 162
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 156
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 155
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 155
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 154
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 153
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 152
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 152
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 150
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 149
Progetto atrofia multisistemica: risultati preliminari. 149
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 147
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 146
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 146
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 145
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 144
Bipallidal lesions induce delayed and progressive parkinsonism 143
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 140
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 140
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 139
Autoscopic phenomena: case report and review of literature. 138
Attention network in AD and DLB patients: a resting fMRI study. 138
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 138
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 137
Improving diagnostic accuracy of DLB: An MRI study 136
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 135
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 135
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 134
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 132
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 132
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 132
Acute akinesia or akinetic crisis in Parkinson's disease. 131
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 130
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis 129
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 129
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 128
Heat shock protein 70: implication for Alzheimer's disease 127
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 126
Donepezil vs vitamina E nella malattia di Alzheimer (AD): confronto tra P300 Event Related Potential e Test Neuropsicologici. 126
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 126
3D localization of interictal epileptic activity by neuromagnetic method 125
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 125
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 124
A stage-based approach to therapy in parkinson’s disease 124
Pathological Gambling in PD is reduced by Amantadine 123
Atrofia Multisistemica: approccio diagnostico multidisciplinare 123
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 123
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 123
Mitochondrial Involvement in Neurodegenerative Dementia 123
P3 topography in brain lesions 122
Neurite ottica: relazione tra perimetria, PEV e RMN 122
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 122
Acute akinesia in Parkinson disease. 122
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 121
Altitudinal visual stimuli and the cruciform model of evoked potentials. 120
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 120
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 120
Catamenial end-off dose in Parkinson's disease 120
The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study 120
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 119
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 119
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 118
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism 118
L’ecografia transcranica nello studio del parenchima cerebrale: la nostra casistica 117
Are VEP abnormalities in optic neuritis (ON) dependent on plaque size? A reappraisal of the physiopathology of ON based on improved MRI and multiple-lead recordings. 116
Prevalenza dei disturbi motori e non motori nella popolazione di pazienti con demenza a corpi di Lewy afferente al nostro centro per i disordini del movimento e le demenze. 116
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 116
Visual Hallucinations in PD and Lewy body dementias: Old and new hypotheses 115
Mixed resting and postural tremor with overflow in orthostatism is observed in PDD/DLB patients 115
Registrazioni dei potenziali evocati visivi ed evento_correlati in un paziente affetto da sindrome di Balint 114
EEG IN PARKINSON'S DISEASE WITH DEMENTIA PREDICTS THE APPEARANCE OF FLUCTUATING COGNITION. XL Congresso SIN, Padova, novembre 2009. 114
Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study 114
Attivazione dell'emisfero non-dominante in giocatori di scacchi durante la soluzione di complessi problemi strategici 113
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 113
Fisiopatologia della neurite ottica: correlazioni cliniche, elettrofisiologiche e neuroradiologiche 112
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 112
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 112
Polymorphisms of chemokine receptor genes in Alzheimer's and Parkinson's Patients 112
Cohort study on tremor in DLB: prevalence and features 112
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 112
Clinical and electrohysiological analysis of the fluctuating cognition in patients affected by Dementia with Lewy Bodies. 112
Paradoxical kinesia in parkinsonian patients surviving earthquake. 112
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 111
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study 111
Uso della amantadina nel trattamento delle discinesie e fluttuazioni motorie in pazienti affetti da Morbo di Parkinson 111
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease 111
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 110
Totale 14.850
Categoria #
all - tutte 109.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021416 0 0 0 0 0 0 0 0 0 216 111 89
2021/20221.082 27 25 27 129 60 31 26 95 71 46 175 370
2022/20233.715 301 430 246 390 366 759 240 244 492 55 89 103
2023/20241.714 133 75 124 85 92 432 429 52 37 63 29 163
2024/20254.251 266 717 618 126 103 156 100 241 340 260 437 887
2025/20269.251 840 336 992 1.226 799 630 1.525 621 1.608 674 0 0
Totale 30.113